What does Lucida Medical do?

Lucida Medical is an AI-driven medical technology company based in Cambridge, United Kingdom. Founded in 2019 by Prof. Evis Sala and Dr. Antony Rix, the company focuses on developing artificial intelligence software for cancer detection and diagnosis through medical imaging. Their mission is to enhance the accuracy and efficiency of cancer screening using MRI technology. The primary product of Lucida Medical is Pi™, a CE-marked medical device software designed to assist in prostate cancer diagnosis. Pi™ analyzes pre-biopsy MRI scans, identifying the prostate and suspicious lesions, and generates a template report with risk scores. This automated analysis helps radiologists save time by streamlining routine image analysis tasks. Lucida Medical's technology integrates with existing hospital systems, collaborating with major vendors like GE Healthcare. The company was selected for GE Healthcare's Edison™ Accelerator programme, where Pi™ was implemented in the East Midlands Imaging Network, facilitating the automatic processing of anonymized prostate MRI studies for radiologist review.